NCT05346367View on ClinicalTrials.gov

Improving Therapeutic Ratio With Hypo Fractionated Stereotactic Radiotherapy for Brain Metastases

NARecruitingINTERVENTIONAL
Enrollment

130

Participants

Timeline

Start Date

July 18, 2022

Primary Completion Date

March 31, 2027

Study Completion Date

March 31, 2027

Conditions
Brain Metastases
Interventions
RADIATION

SRT

SRT

RADIATION

fSRT

fSRT

Trial Locations (1)

2262 BA

RECRUITING

Haaglanden Medisch Centrum, Leidschendam

Sponsors
All Listed Sponsors
lead

Haaglanden Medical Centre

OTHER

NCT05346367 - Improving Therapeutic Ratio With Hypo Fractionated Stereotactic Radiotherapy for Brain Metastases | Biotech Hunter | Biotech Hunter